You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 157 No. 12, 23 JUNE 1997 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  REVIEW ARTICLE
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Management of Diabetes Insipidus in Adults

Irwin Singer, MD; James R. Oster, MD; Lawrence M. Fishman, MD

Arch Intern Med. 1997;157(12):1293-1301.


Abstract



The management of patients with diabetes insipidus can be confusing because of the disorder's variable pathophysiology, the numerous medications used, and the possible complications related to their use. Nevertheless, the primary care physician, rather than the subspecialist, will increasingly be called on to manage patients with such relatively uncommon conditions in the future. If a few basic facts and principles are kept in mind, the care of most patients with diabetes insipidus can be successful. A comprehensive, practical review of the short- and long-term therapy for patients with diabetes insipidus, including central diabetes insipidus, nephrogenic diabetes insipidus, and the "excessive vasopressinase syndrome," is presented. The use of single and multidrug regimens, and of the newly marketed oral formulation of desmopressin acetate, is described for common clinical settings.

Arch Intern Med. 1997;157:1293-1301



Author Affiliations



From the Medical and Research Services, Department of Veterans Affairs Medical Center, and the Department of Medicine, University of Miami School of Medicine, Miami, Fla.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Activation of vasopressin neurons leads to phenotype progression in a mouse model for familial neurohypophysial diabetes insipidus
Hiroi et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010;298:R486-R493.
ABSTRACT | FULL TEXT  

Considerations in Fluids and Electrolytes After Traumatic Brain Injury
Rhoney and Parker
Nutr Clin Pract 2006;21:462-478.
ABSTRACT | FULL TEXT  

Postoperative Care Following Pituitary Surgery
Dumont et al.
J Intensive Care Med 2005;20:127-140.
ABSTRACT  

Paradoxical Antidiuretic Effect of Thiazides in Diabetes Insipidus: Another Piece in the Puzzle
Loffing
J. Am. Soc. Nephrol. 2004;15:2948-2950.
FULL TEXT  

Unexplained polyuria and non-obstructive hydronephrosis in a urological department
Korzets et al.
Nephrol Dial Transplant 2004;19:2410-2412.
FULL TEXT  

Diabetes Insipidus Due to Streptococcus pneumoniae Meningitis
Franco-Paredes et al.
Arch Intern Med 2001;161:1114-1115.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.